Severe Cutaneous Dissemination of Nocardia niigatensis in a Patient Receiving Immunosuppression for Myasthenia Gravis: A Case Report
Nocardia niigatensis is a rare pathogen whose infections can be difficult to recognize in patients receiving immunosuppressive therapy for myasthenia gravis (MG). The clinical presentation may mimic other infectious or inflammatory conditions, delaying diagnosis. A 36-year-old man receiving high-dose prednisolone for MG presented with loss of consciousness, fever, and progressive lower-limb swelling after months of dysphagia and muscle weakness. He required urgent resuscitation and intensive care. Examination showed widespread erythematous, scaly lesions and a large fluctuant collection in the right leg. Incision and drainage yielded 2.5 L of pus. Microscopy demonstrated branching filamentous gram-positive bacilli, and culture yielded chalky colonies. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and 16S ribosomal RNA gene sequencing identified the organism as N. niigatensis. During prolonged trimethoprim-sulfamethoxazole therapy, the skin lesions improved noticeably within one month. This case highlights the need to consider nocardiosis in immunosuppressed patients with atypical cutaneous or systemic infections. Early molecular identification at the species level and targeted antimicrobial therapy are essential for optimal outcomes.
Authors
- Mustafa Al Shaaibi
- Mubarak Al Yaqoobi
- Amal Al Jabri
- Amal Al Kalbani
- Hala Al Hinai
- Amira Al Dhabbari
- Azza Al Rashdi
Institutions
- Khoula Hospital (OM)
Publication Details
- Journal
- Cureus
- Published
- 2026-11-17
- DOI
- https://doi.org/10.7759/cureus.119851
- Primary Topic
- Actinomycetales infections and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00